TNF and acute promyelocytic leukemia: Thus, autoimmune markers [Rheumatoid Factor (RF), high-sensitivity C-reactive protein (hsCRP), lupus anticoagulant (LA), homocysteine (Hcy), anti-cyclic citrullinated peptide (anti-CCP), interleukin-6 (IL-6), asymmetrical dimethylarginine (ADMA), anti-double stranded DNA (anti-dsDNA), soluble vascular adhesion molecule-1 (sVCAM-1), N-terminal pro b-type natriuretic peptide (NT-proBNP), antiphospholipid antibodies (APL), tumor necrosis factor-alpha (TNF-α), fibrinogen, and anticardiolipin antibodies (aCL)] have been proposed as additional tools to predict CVD in autoimmune patients (6–10).